3rd Circ. Buries Pfizer Investor Suit Over Alzheimer's Med
The Third Circuit refused Friday to revive a class of Pfizer Inc. shareholders' securities fraud suit accusing its executives of making false statements over clinical trial data related to the development...To view the full article, register now.
Already a subscriber? Click here to view full article